HAYWARD, Calif. — Microvi Biotechnologies has been awarded a $1.5 million grant from the National Institute of Environmental Health Sciences (NIEHS) to demonstrate at scale a novel technology for the treatment of 1,4-dioxane in water, according to a press release.
This work will follow the work done during a Phase I grant, where a prototype of a first-of-its-kind biological treatment technology for dioxane degradation called MB-DX™ was developed, the release noted.
“1,4-dioxane is among the most widely detected organic contaminants in groundwater and drinking water, with 13 percent of U.S. drinking water sources tested in 2013 showing evidence of 1,4-dioxane. Available treatment solutions are expensive and energy intensive and often have inconsistent performance records,” said Thomas Mohr, senior hydrologist with the Santa Clara Valley Water District and a thought leader in the field of 1,4-dioxane.
According to Mohr, Microvi's MB-DX™ technology uses 1,4-dioxane degrading microbes to overcome bioreactor system instability and clogging, the release reported.
“I congratulate Microvi Biotechnologies in Hayward and their CEO Dr. Fatemeh Shirazi on receiving this federal grant to help them pursue the development of a critical technology to keep our water safe,” said Congressman Eric Swalwell (CA-15). “Technological innovations like the sustainable solutions developed at Microvi are driving our economic growth in the Bay Area and I will keep advocating for strong public-private partnerships to support this sector.”